PMID- 26361959 OWN - NLM STAT- MEDLINE DCOM- 20170131 LR - 20181113 IS - 1423-0380 (Electronic) IS - 1010-4283 (Linking) VI - 37 IP - 2 DP - 2016 Feb TI - Regulation of beta-catenin transcription activity by leupaxin in hepatocellular carcinoma. PG - 2313-20 LID - 10.1007/s13277-015-4060-4 [doi] AB - In human cancers, beta-catenin is accumulated in the nucleus and activates mRNA transcription of many oncogenic genes, such as cyclin D1 and c-myc. However, the mechanism of beta-catenin-mediated transcriptional activation remains largely unknown. In the present study, we identified leupaxin, an adaptor protein sharing homology with the focal adhesion protein, as a novel coactivator for beta-catenin in human hepatocellular carcinoma (HCC). We show that leupaxin could interact with beta-catenin and enhance its transcriptional activity through recruitment of coactivator complex, including steroid receptor coactivator 1 (SRC-1) and P300. As a result, leupaxin regulates HCC cell proliferation and cell-cycle progression in the presence of intact Wnt/beta-catenin signaling. Furthermore, leupaxin is overexpressed in HCC tissues and correlated with mRNA levels of cyclin D1 and c-myc. Therefore, this is the first demonstration of a role for the leupaxin in the regulation of HCC progression, at least in part, by enhancing beta-catenin transcription activity. FAU - Shi, Jia AU - Shi J AD - Department of Pediatric Surgery, Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, No. 1665, Kongjiang Road, Shanghai, 200092, China. FAU - Wu, Wen-Jie AU - Wu WJ AD - Department of Pediatric Surgery, Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, No. 1665, Kongjiang Road, Shanghai, 200092, China. FAU - Hu, Gang AU - Hu G AD - Key Laboratory of Kidney Disease Pathogenesis and Intervention of Hubei Province, College of Medicine, Hubei Polytechnic University, Huangshi, Hubei, 435003, People's Republic of China. FAU - Yu, Xin AU - Yu X AD - Key Laboratory of Kidney Disease Pathogenesis and Intervention of Hubei Province, College of Medicine, Hubei Polytechnic University, Huangshi, Hubei, 435003, People's Republic of China. FAU - Yu, Ge-Shu AU - Yu GS AD - Key Laboratory of Kidney Disease Pathogenesis and Intervention of Hubei Province, College of Medicine, Hubei Polytechnic University, Huangshi, Hubei, 435003, People's Republic of China. FAU - Lu, Han AU - Lu H AD - Department of Anesthesiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine (SJTU-SM), 197, Rui Jin Er Road, Shanghai, 200025, People's Republic of China. FAU - Yang, Ming-Liang AU - Yang ML AD - Department of Anesthesiology, Jianli Second People's Hospital, Jianli, Hubei, 433325, People's Republic of China. FAU - Liu, Bin AU - Liu B AD - Key Laboratory of Kidney Disease Pathogenesis and Intervention of Hubei Province, College of Medicine, Hubei Polytechnic University, Huangshi, Hubei, 435003, People's Republic of China. liubin3575630@163.com. FAU - Wu, Zhi-Xiang AU - Wu ZX AD - Department of Pediatric Surgery, Xin Hua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, No. 1665, Kongjiang Road, Shanghai, 200092, China. zhixiangwu@yahoo.com. LA - eng PT - Journal Article DEP - 20150911 PL - Netherlands TA - Tumour Biol JT - Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine JID - 8409922 RN - 0 (CTNNB1 protein, human) RN - 0 (Cell Adhesion Molecules) RN - 0 (LPXN protein, human) RN - 0 (Phosphoproteins) RN - 0 (beta Catenin) SB - IM MH - Blotting, Western MH - Carcinoma, Hepatocellular/genetics/metabolism/*pathology MH - Cell Adhesion Molecules/genetics/*metabolism MH - Chromatin Immunoprecipitation MH - Gene Expression Regulation, Neoplastic/*genetics MH - Gene Knockdown Techniques MH - Humans MH - Liver Neoplasms/genetics/metabolism/*pathology MH - Phosphoproteins/genetics/*metabolism MH - Real-Time Polymerase Chain Reaction MH - Transcription, Genetic MH - beta Catenin/*biosynthesis/genetics OTO - NOTNLM OT - Coactivator OT - Hepatocellular carcinoma (HCC) OT - Leupaxin OT - Transcription activity OT - beta-catenin EDAT- 2015/09/13 06:00 MHDA- 2017/02/01 06:00 CRDT- 2015/09/13 06:00 PHST- 2015/07/09 00:00 [received] PHST- 2015/09/04 00:00 [accepted] PHST- 2015/09/13 06:00 [entrez] PHST- 2015/09/13 06:00 [pubmed] PHST- 2017/02/01 06:00 [medline] AID - 10.1007/s13277-015-4060-4 [pii] AID - 10.1007/s13277-015-4060-4 [doi] PST - ppublish SO - Tumour Biol. 2016 Feb;37(2):2313-20. doi: 10.1007/s13277-015-4060-4. Epub 2015 Sep 11.